‌

US Patent 9457067 Sialylated glycoprotein compositions and uses thereof

Patent 9457067 was granted and assigned to Ultragenyx Pharmaceutical on October, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Ultragenyx Pharmaceutical

Current Assignee

Ultragenyx Pharmaceutical

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

94570670

Patent Inventor Names

Gabrielle Morris0

Steven Jungles0

Michael Vellard0

Emil D. Kakkis0

Jeff Grubb0

Date of Patent

October 4, 2016

Patent Application Number

146391710

Date Filed

March 5, 2015

Patent Primary Examiner

‌

Suzanne M Noakes

Patent abstract

The present application relates to sialylated glycoprotein compositions and methods of their use in treating various conditions and disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9457067 Sialylated glycoprotein compositions and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API